Provided by Tiger Fintech (Singapore) Pte. Ltd.

Infinity Pharmaceuticals, Inc.

0.0160
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.45M
PE:-0.03
High:0.0160
Open:0.0160
Low:0.0160
Close:0.0160
Loading ...

BRIEF-Infinity Pharmaceuticals Announces Stockholder Approval Of Merger With Mei Pharma

Reuters
·
15 Jul 2023

Infinity Pharma (INFI) Stock Up on Advancing Cancer Study

Zacks Investment Research
·
11 Jul 2023

BRIEF-MEI Pharma Provides Final Reminder To Shareholders To Vote For Merger With Infinity Pharmaceuticals

Reuters
·
11 Jul 2023

BRIEF-Infinity Pharmaceuticals Inc - Glass Lewis And Iss Recommend That Stockholders Of Infinity And Mei Vote For Merger Between Two Companies

Reuters
·
10 Jul 2023

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)

Business Wire
·
10 Jul 2023

BRIEF-ISS Recommends Infinity Pharmaceuticals Stockholders Vote For The Merger With MEI Pharma Inc

Reuters
·
05 Jul 2023

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Business Wire
·
05 Jul 2023

BRIEF-MEI Pharma Highlights Recommendation By Leading Independent Proxy Advisory Firm ISS To Vote 'FOR' Pending Transaction With Infinity Pharmaceuticals

Reuters
·
05 Jul 2023

BRIEF-Infinity Pharmaceuticals Says On June 27, Got Letter From Nasdaq Determining To Delist Co’S Common Stock From Nasdaq

Reuters
·
01 Jul 2023

BRIEF-Mei Pharma Issued Letter To Shareholders Reiterating Board Of Directors Recommendation To Vote For Pending Transaction With Infinity Pharmaceuticals

Reuters
·
29 Jun 2023

BRIEF-Anson Funds And Cable Car Capital Issue Statement Regarding Proposed Transaction Between Mei Pharma And Infinity Pharmaceuticals

Reuters
·
27 Jun 2023

Press Release: Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals

Dow Jones
·
27 Jun 2023